FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to laboratory diagnostics, and can be used to predict the risk of death in patients with COVID-19. Body weight index, thrombocyte, neutrophil, monocyte, D-dimer, high-sensitivity troponin, procalcitonin, C-reactive protein and ferritin are measured. Thereafter, numerical values are processed by original formula to calculate risk of fatal outcome (P). If P is equal to 0.5 or more, a high risk of fatal outcome is predicted.
EFFECT: method, being minimally invasive and easy to implement, as well as available for outpatient and hospital treatment, allows high accuracy and efficiency of prediction of risk of fatal outcome in elderly and senile patients with COVID-19-associated pneumonia.
1 cl, 1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
| METHOD OF PREDICTING THE RISK OF DEVELOPING CHRONIC HEART FAILURE IN PATIENTS WHO HAVE HAD A NEW CORONAVIRUS INFECTION COVID-19 | 2023 |
|
RU2805601C1 |
| METHOD FOR PREDICTING THE RISK OF HOSPITAL MORTALITY IN PATIENTS WITH A NEW CORONAVIRUS INFECTION COVID-19 | 2022 |
|
RU2780522C1 |
| METHOD FOR PREDICTION OF LETHAL OUTCOME IN PATIENTS WITH CYTOKINE STORM ASSOCIATED WITH COVID-19 | 2022 |
|
RU2825710C2 |
| METHOD FOR PREDICTION OF LETHAL OUTCOME IN SARS-CoV-2-ASSOCIATED PNEUMONIA | 2023 |
|
RU2825705C1 |
| METHOD FOR RAPID DIAGNOSIS OF THE SEVERITY OF PNEUMONIA IN COVID-19 | 2022 |
|
RU2789426C1 |
| METHOD FOR PREDICTING PROBABILITY OF DEATH IN PATIENTS WITH COVID-19 HOSPITALIZED ON BASIS OF LABORATORY AND INSTRUMENTAL STUDIES | 2023 |
|
RU2806726C1 |
| METHOD FOR PREDICTING THE RISK OF DEATH WITHIN 6 MONTHS AFTER SUFFERING A NEW CORONAVIRUS INFECTION COVID-19 | 2021 |
|
RU2766302C1 |
| METHOD FOR PREDICTING RISK OF DEATH AT HOSPITAL STAGE IN PATIENTS WITHOUT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION WHO HAVE UNDERGONE NEW COVID-19 CORONAVIRUS INFECTION, TAKING INTO ACCOUNT THEIR IMMUNOLOGICAL STATUS | 2022 |
|
RU2781565C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN ASSOCIATED WITH SARS-CoV-2 | 2023 |
|
RU2816437C1 |
